Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


13.08.2018

1 Am J Cancer Res
1 Ann Diagn Pathol
1 Anticancer Res
1 Biochem Cell Biol
1 Biomed Pharmacother
1 BMJ Open
1 Br J Cancer
1 Cell Death Differ
1 Clin Microbiol Infect
1 Curr Med Sci
1 Eur J Nucl Med Mol Imaging
1 Eur Rev Med Pharmacol Sci
1 Gene
6 Gynecol Oncol
1 Indian J Med Microbiol
1 Inflamm Bowel Dis
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
4 Int J Gynecol Cancer
1 Int J Mol Sci
1 Intern Med
1 J Biomed Sci
1 J Cancer
1 J Cell Physiol
1 J Clin Oncol
1 J Cytol
5 J Glob Oncol
1 J Prev Med Public Health
3 Medicine (Baltimore)
1 Nurs Womens Health
1 Oncotarget
1 Parasitol Res
1 Sci Rep
1 Trials
1 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cancer Res

  1. SU K, Zhao Q, Bian A, Wang C, et al
    A novel positive feedback regulation between long noncoding RNA UICC and IL-6/STAT3 signaling promotes cervical cancer progression.
    Am J Cancer Res. 2018;8:1176-1189.
    PubMed     Text format     Abstract available


    Ann Diagn Pathol

  2. KUDELA E, Visnovsky J, Balharek T, Farkasova A, et al
    Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.
    Ann Diagn Pathol. 2018;35:16-20.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. PRODROMIDOU A, Machairas N, Spartalis E, Kostakis ID, et al
    Transperitoneal Versus Extraperitoneal Laparoscopic Lymphadenectomy for Gynecological Malignancies: A Systematic Review and Meta-analysis.
    Anticancer Res. 2018;38:4677-4681.
    PubMed     Text format     Abstract available


    Biochem Cell Biol

  4. XIE Q, Lin S, Zheng M, Cai Q, et al
    Long noncoding RNA NEAT1 promoted the growth of cervical cancer cells via sponging miR-9-5p.
    Biochem Cell Biol. 2018 Aug 10. doi: 10.1139/bcb-2018-0111.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  5. HAN HW, Zheng CS, Chu SJ, Sun WX, et al
    The evaluation of potent antitumor activities of shikonin coumarin-carboxylic acid, PMMB232 through HIF-1alpha-mediated apoptosis.
    Biomed Pharmacother. 2018;97:656-666.
    PubMed     Text format     Abstract available


    BMJ Open

  6. MURENZI G, Dusingize JC, Rurangwa T, Sinayobye JD, et al
    Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda.
    BMJ Open. 2018;8:e020432.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. AOKI Y, Ochiai K, Lim S, Aoki D, et al
    Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer.
    Br J Cancer. 2018 Aug 3. pii: 10.1038/s41416-018-0206.
    PubMed     Text format     Abstract available


    Cell Death Differ

  8. HUO FC, Pan YJ, Li TT, Mou J, et al
    PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.
    Cell Death Differ. 2018 Aug 6. pii: 10.1038/s41418-018-0178.
    PubMed     Text format     Abstract available


    Clin Microbiol Infect

  9. DE THURAH L, Bonde J, Lam JUH, Rebolj M, et al
    Not all HPV nucleic acid tests are equal: only those calibrated to detect high grade lesions matter for cervical screening: Response to 'Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: syste
    Clin Microbiol Infect. 2018;24:438-439.
    PubMed     Text format    


    Curr Med Sci

  10. ZHENG HY, Shen FJ, Tong YQ, Li Y, et al
    PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway.
    Curr Med Sci. 2018;38:115-123.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  11. LIMA GM, Matti A, Vara G, Dondi G, et al
    Prognostic value of posttreatment (18)F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parame
    Eur J Nucl Med Mol Imaging. 2018 Aug 2. pii: 10.1007/s00259-018-4077.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  12. YU Y, Shen HM, Fang DM, Meng QJ, et al
    LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.
    Eur Rev Med Pharmacol Sci. 2018;22:4812-4819.
    PubMed     Text format     Abstract available


    Gene

  13. HU L, Jia M, Zhou J, Ma H, et al
    Genetic variants within 17q12 are associated with the risk of cervical cancer in the Han Chinese population.
    Gene. 2018 Aug 7. pii: S0378-1119(18)30892-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  14. WILFORD J, Osann K, Hsieh S, Monk B, et al
    Validation of PROMIS emotional distress short form scales for cervical cancer.
    Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31086.
    PubMed     Text format     Abstract available

  15. STOLER MH, Wright TC Jr, Parvu V, Vaughan L, et al
    The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.
    Gynecol Oncol. 2018;149:498-505.
    PubMed     Text format     Abstract available

  16. CHARAKORN C, Thadanipon K, Chaijindaratana S, Rattanasiri S, et al
    The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
    Gynecol Oncol. 2018;150:190-200.
    PubMed     Text format     Abstract available

  17. MARTINEZ-GOMEZ C, Angeles MA, Martinez A, Ferron G, et al
    Laparoscopic anterior pelvic exenteration in 10 steps.
    Gynecol Oncol. 2018;150:201-202.
    PubMed     Text format    

  18. STOLNICU S, Barsan I, Hoang L, Patel P, et al
    Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Gynecol Oncol. 2018 May 30. pii: S0090-8258(18)30848.
    PubMed     Text format     Abstract available

  19. CUNNINGHAM-ERVES J, Forbes L, Ivankova N, Mayo-Gamble T, et al
    Black mother's intention to vaccinate daughters against HPV: A mixed methods approach to identify opportunities for targeted communication.
    Gynecol Oncol. 2018 Mar 24. pii: S0090-8258(18)30219.
    PubMed     Text format     Abstract available


    Indian J Med Microbiol

  20. WAGH P, Kulkarni P, Kerkar S, Warke H, et al
    Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer.
    Indian J Med Microbiol. 2018;36:207-210.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  21. LAMBDIN JT, Borum M
    Cervical Cancer Screening in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5061940. doi: 10.1093.
    PubMed     Text format    


    Int J Clin Oncol

  22. YAHATA H, Kobayashi H, Sonoda K, Kodama K, et al
    Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer.
    Int J Clin Oncol. 2018 Aug 9. pii: 10.1007/s10147-018-1327.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  23. RIZZUTO I, Nalam M, Jiang J, Linder A, et al
    Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia.
    Int J Gynaecol Obstet. 2017 Dec 17. doi: 10.1002/ijgo.12431.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  24. YOU KY, Zhou XH, Jiang YH, Bi ZF, et al
    The Selection of Time Interval Between Surgery and Adjuvant Therapy in Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2018 Aug 1. doi: 10.1097/IGC.0000000000001307.
    PubMed     Text format     Abstract available

  25. TOMITA N, Mizuno M, Makita C, Kondo S, et al
    Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
    Int J Gynecol Cancer. 2018 Aug 7. doi: 10.1097/IGC.0000000000001336.
    PubMed     Text format     Abstract available

  26. ZHANG L, He Q, Jiang M, Zhang B, et al
    Diagnosis of Insufficiency Fracture After Radiotherapy in Patients With Cervical Cancer: Contribution of Technetium Tc 99m-Labeled Methylene Diphosphonate Single-Photon Emission Computed Tomography/Computed Tomography.
    Int J Gynecol Cancer. 2018 Aug 7. doi: 10.1097/IGC.0000000000001337.
    PubMed     Text format     Abstract available

  27. LEITAO MM JR
    The LACC Trial: Has Minimally Invasive Surgery for Early-Stage Cervical Cancer Been Dealt a Knockout Punch? An Invited Editorial.
    Int J Gynecol Cancer. 2018 Aug 7. doi: 10.1097/IGC.0000000000001342.
    PubMed     Text format    


    Int J Mol Sci

  28. TYSZKA-CZOCHARA M, Lasota M, Majka M
    Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-beta1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    Intern Med

  29. MURAI K, Imai K, Hotta K, Ito S, et al
    A 10-year History of a Diminutive Rectal Neuroendocrine Tumor.
    Intern Med. 2018;57:677-679.
    PubMed     Text format     Abstract available


    J Biomed Sci

  30. BREWER KD, Weir GM, Dude I, Davis C, et al
    Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
    J Biomed Sci. 2018;25:7.
    PubMed     Text format     Abstract available


    J Cancer

  31. HAN S, Shi X, Liu L, Zong L, et al
    Roles of B7-H3 in Cervical Cancer and Its Prognostic Value.
    J Cancer. 2018;9:2612-2624.
    PubMed     Text format     Abstract available


    J Cell Physiol

  32. PAL D, Sur S, Roy R, Mandal S, et al
    Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line.
    J Cell Physiol. 2018 Aug 4. doi: 10.1002/jcp.26900.
    PubMed     Text format     Abstract available


    J Clin Oncol

  33. SHIN DW, Lee JW, Jung JH, Han K, et al
    Disparities in Cervical Cancer Screening Among Women With Disabilities: A National Database Study in South Korea.
    J Clin Oncol. 2018 Aug 3:JCO2018777912. doi: 10.1200/JCO.2018.77.7912.
    PubMed     Text format     Abstract available


    J Cytol

  34. DAS D, Sengupta M, Basu K, Tirkey M, et al
    Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors.
    J Cytol. 2018;35:153-158.
    PubMed     Text format     Abstract available


    J Glob Oncol

  35. AUSTAD K, Chary A, Xocop SM, Messmer S, et al
    Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: A Mixed-Method Analysis.
    J Glob Oncol. 2018;:1-10.
    PubMed     Text format     Abstract available

  36. CHOPRA SJ, Mathew A, Maheshwari A, Bhatla N, et al
    National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer.
    J Glob Oncol. 2018;:1-15.
    PubMed     Text format     Abstract available

  37. AWOLUDE OA, Oyerinde SO, Akinyemi JO
    Screen and Triage by Community Extension Workers to Facilitate Screen and Treat: Task-Sharing Strategy to Achieve Universal Coverage for Cervical Cancer Screening in Nigeria.
    J Glob Oncol. 2018;:1-10.
    PubMed     Text format     Abstract available

  38. MITTAL P, Chopra S, Pant S, Mahantshetty U, et al
    Standard Chemoradiation and Conventional Brachytherapy for Locally Advanced Cervical Cancer: Is It Still Applicable in the Era of Magnetic Resonance-Based Brachytherapy?
    J Glob Oncol. 2018;:1-9.
    PubMed     Text format     Abstract available

  39. CHUANG L
    Can We Apply National Cancer Grid of India Consensus Guidelines for the Management of Cervical Cancer in Low-Resource Settings?
    J Glob Oncol. 2018;:1-4.
    PubMed     Text format    


    J Prev Med Public Health

  40. SEO M, Langabeer J
    Determinants of Potentially Unnecessary Cervical Cancer Screenings in American Women.
    J Prev Med Public Health. 2018;51:181-187.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  41. LACHKAR B, Minaguchi T, Akiyama A, Liu S, et al
    Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin.
    Medicine (Baltimore). 2018;97:e11392.
    PubMed     Text format     Abstract available

  42. YANG Q, Tang J, Xiao L
    Disease-free survival after robotic-assisted laparoscopic total pelvic exenteration for recurrent cervical adenocarcinoma: A case report.
    Medicine (Baltimore). 2018;97:e11611.
    PubMed     Text format     Abstract available

  43. LIU H, Zhang Y, Chang J, Liu Z, et al
    Differential expression of neuroendocrine markers, TTF-1, p53, and Ki-67 in cervical and pulmonary small cell carcinoma.
    Medicine (Baltimore). 2018;97:e11604.
    PubMed     Text format     Abstract available


    Nurs Womens Health

  44. CHEUN ASA, Loomis J
    A Culturally Sensitive Approach to Cervical Cancer Prevention in the Latina Population Using the Promotora Model.
    Nurs Womens Health. 2018;22:338-345.
    PubMed     Text format     Abstract available


    Oncotarget

  45. HUGO DE ALMEIDA V, Guimaraes IDS, Almendra LR, Rondon AMR, et al
    Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.
    Oncotarget. 2018;9:30594-30609.
    PubMed     Text format     Abstract available


    Parasitol Res

  46. NIKAS I, Hapfelmeier A, Mollenhauer M, Angermeier D, et al
    Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations.
    Parasitol Res. 2018;117:1443-1451.
    PubMed     Text format     Abstract available


    Sci Rep

  47. JACOBS BA, Chetty A, Horsnell WGC, Schafer G, et al
    Hookworm exposure decreases human papillomavirus uptake and cervical cancer cell migration through systemic regulation of epithelial-mesenchymal transition marker expression.
    Sci Rep. 2018;8:11547.
    PubMed     Text format     Abstract available


    Trials

  48. JI S, Hu Q, Zhu J, Chen J, et al
    Combined pretreatment with (18)F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial.
    Trials. 2018;19:416.
    PubMed     Text format     Abstract available


    Zhonghua Zhong Liu Za Zhi

  49. LIU BB, Zhu YL, Zhang WH, Zhang H, et al
    [Clinical analysis of 128 cases of cervical lesion diagnosed by multi-point biopsy of colposcopy and endocervical curettage].
    Zhonghua Zhong Liu Za Zhi. 2018;40:539-542.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: